[Tissue plasminogen activator and intravitreal gas for the treatment of Terson's syndrome: case report].
The case of a 35 year-old male patient is reported. The patient had a clinical history of craniocerebral trauma and premacular hemorrhage of Terson syndrome in the left eye. After waiting for 45 days, without hemorrhage resolution, the patient received an intravitreal injection of sulfur hexafluoride gas and tPA; an almost complete hemorrhage absorption occurred after a week as well as a considerable improvement of visual acuity. In the report, relevant aspects of Terson syndrome and of intravitreal injection of gas and tPA are also described through a literature review.
Serracarbassa
Pedro Durães
PD
Departamento de Oftalmologia, Hospital do Servidor Público Estadual Francisco Morato de Oliveira, São Paulo, SP, Brasil. serracar@brfree.com.br
Rodrigues
Luciana Duarte
LD
Rodrigues
Juliana Ribeiro
JR
D000328:Adult; D006801:Humans; D007267:Injections; D008297:Male; D012166:Retinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D020206:Subarachnoid Hemorrhage, Traumatic / Q000150:complications*; D013459:Sulfur Hexafluoride / Q000627:therapeutic use*; D013577:Syndrome; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010959:Tissue Plasminogen Activator; D013459:Sulfur Hexafluoride